Phase II study of thoracic radiotherapy concurrently combined with cisplatin and vinorelbine chemotherapy followed by sequential therapy with TS-1 for inoperable locally advanced non-small cell lung cancer
Phase 2
- Conditions
- inoperable locally advanced stage IIIA/IIIB non-small cell lung cancer
- Registration Number
- JPRN-UMIN000002381
- Lead Sponsor
- ational Hospital Study Group for Lung Cancer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 65
Inclusion Criteria
Not provided
Exclusion Criteria
1.Infections 2.Apparent interstitial pneumonitis or fibrosis on chest CT 3.Irradiation field larger than half of a ipsilateral lung 4.Ileus 5.Neuropathy (motor, sensory) 6.Severe complications(liver cirrhosis, diabetes mellitus, Clinically significant heart disease, etc.) 7.Myocardial infarction within the last 6 months 8.Another active cancer 9.Pregnancy, intent to become pregnant, or breast-feeding 10.Other non eligible cases judged by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method